tokenizing psychedelic IP on https://t.co/Yjo5AJBkVY | 💜 | incubated by @molecule_dao and @bioprotocol | sponsor of @BeeARDai 🐝, eDMT and LSD/psilocin for longevity
A major unresolved issue in the realm of psychedelic medicine is whether patients actually need to experience a hallucinatory trip to receive the therapeutic benefits. Based on two mouse studies published this week, the answer might be no.
Researchers suggest that the positive medical outcomes and the hallucinogenic effects operate through completely distinct neurological pathways in the brain. While these findings are promising, the science is still in its preliminary stages, and absolutely no testing has been conducted on humans yet. 🧵